Cash Flow Immuno-Biological Laboratories Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
300.00
209.00
124.00
-280.00
-250.00
-310.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-6.00
-37.00
18.00
-26.00
31.00
32.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
301.00
183.00
133.00
26.00
-93.00
-194.00
Cash Flow from Investing Activities
-116.00
-53.00
-24.00
30.00
-155.00
-17.00
Cash Flow from Financing Activities
-27.00
-31.00
0.00
0.00
143.00
-216.00
Net Cash Inflow / Outflow
157.00
95.00
112.00
59.00
-102.00
-422.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
-2.00
2.00
2.00
1.00
4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Immuno-Biological Laboratories Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
300.562
825.458
-525.00
-63.59%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-6.801
-621.217
615.00
98.91%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
301.093
297.842
4.00
1.09%
Cash Flow from Investing Activities
-116.463
7.03
-123.00
-1756.66%
Cash Flow from Financing Activities
-27.136
-375.592
348.00
92.78%
Net Cash Inflow / Outflow
157.694
-55.354
212.00
384.88%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.2
15.366
-15.00
-98.70%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 64.09% vs 37.17% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
301.09
183.50
64.09%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
